INTRODUCTION
There is a high prevalence of hepatitis B virus (HBY) infection in institutions caring for mentally handicapped patientslv'. Hepatitis C virus (HCY) is frequently associated with chronic liver disease, is a major cause of chronic viral hepatitis worldwide-and shares some routes of transmission with HBy3-S. The prevalence of HCY infection in mental institutions has not yet been clearly established. Previous reports are few and conflicting, with the prevalence of HCY antibodies in institutions varying from 0% in the US and Canada to 36% in Spain6--8. We have studied 101 patients from two institutions in England caring for adults with mental handicap, determining the prevalence of antibodies to both hepatitis B and hepatitis C viruses.
METHODS
All patients studied were cared for by two institutions in South-East England that provide long-term care for adults with mental handicap. They had an IQ of less than 70, with onset of learning difficulty before the age of 16 years. Causes of learning disability included Down's syndrome, childhood meningitis and hypoxic birth injury. Information concerning duration of care within the institutions was not available, but most patients had been known for many years. Sera were tested for HCY antibody with the Biokit (Launch Diagnostics UK) second generation ELISA. Hepatitis B core antibody (HBcAb) was assayed with the Organon Uni-Form test, followed by hepatitis B surface antigen (HBsAg), if indicated, by an in-house-developed competitive radioimmunoassay. HBcAb positivity was used as a marker of previous HBY infection", Chi-square analysis was used for binomial variables.
RESULTS
Of the 101 patients, 67 were inpatients and 34 outpatients (including 3 ex-inpatients). There were 59 men and 42 women. Mean age was 44.1 years (range 25-79). None tested positive for HCY antibody. Forty-three patients (42.6%) were positive for HBcAb. The highest prevalence was in inpatients, of whom 50.9% had the antibody, compared with 26.5% of outpatients (P<0.02). Overall, more men than women were HBcAb positive (50.8% versus 31.0%, P< 0.05). Amongst the inpatients, 62.5% of men compared with 33.3% of women were HBcAb positive (P<0.02). Of the 43 HBcAb positive cases 14 (32.6%) were chronic carriers (HBsAg present), with equal proportions of men and women (Table 1) .
DISCUSSION
Institutionalized patients are not only at increased risk of HBY infectionl-I; they are also at high risk of remaining HBsAg positive'", Possible routes of transmission of HBY in institutions include biting, scratching and inapparent percutaneous exposure (such as sharing of toothbrushes and razors) as well as sexual contact10. Our study confirms earlier reports by disclosing very high levels of exposure to HBV, with evidence of past infection in 42.6% of patients, of whom one-third were HBsAg positive. The highest prevalence of exposure to HBV was in inpatients, probably because their exposure was greater than that of outpatients. The particularly high prevalence in inpatient males (62.5%) perhaps reflects more aggressive behaviour and hence greater exposure to bites and scratches.
Possible routes of HCV infection are parenteral, percutaneous, or sexual contact, although sexual transmission is less frequent than with HBV3. Despite the lower levels of viraemia in chronic HCV infection, biting, scratching, inapparent percutaneous exposure and sexual contact have all resulted in HCV infection 3,5,11. In the UK evidence of HCV infection is rare, being found in only O.OI0 .02% of apparently healthy blood donorsl '. With such a low population prevalence, our observation that HCV infection was absent in the 101 patients allows one of two conclusions-either HCV is not easily transmitted in this setting or no index case had been introduced into this population. Reports published to date suggest that the reality lies somewhere between the two. In Spain, which has a relatively high population seroprevalcncel l, 36% of patients in an institution caring for those with mental handicap were found to have HCV antibodies". In the USA, where there is a lower population seroprevalence, none of 113 adult outpatients with learning disability tested positive for HCV antibodies". An earlier study from the UK reported a 5.6% prevalence!". However, both this study and the one from Spain used a first generation HCV antibody test and confirmatory tests were not done (thus some of these results may have been falsely pcsitivej'>. A group from the north of England, using a second generation HCV antibody test as we did, found no casesl".
The difference in HBV and HCV infection rates in these institutions caring for people with mental handicap is striking. To help confirm whether transmission of HCV occurs in this setting it would be interesting to know the rate 
